天然产物研究与开发 ›› 2017, Vol. 29 ›› Issue (增刊1): 190-193.doi: 10.16333/j.1001-6880.2017.S.038

• 开发研究 • 上一篇    下一篇

紫杉醇对肝癌细胞HEPG2的抑制作用初探

袁程昱1,刘远河2,柴小翠2,康薇2,3*   

  1. 1 湖北大学化学与化工学院,武汉 430062;2矿区环境污染控制与修复湖北省重点实验室;3湖北理工学院环境科学与工程学院,黄石 435003
  • 出版日期:2017-08-02 发布日期:2017-08-02

Inhibitory Effect of Paclitaxel to the Liver Cancer Cell HEPG2

YUAN Cheng-yu1,LIU Yuan-he2,CAI Xiao-cui2,KANG Wei2,3*   

  1. 1 School of Chemistry and Chemical Engineering,Hubei University,Wuhan430062,China; 2Hubei Provincial Key Laboratory of Mining Area Enivironmental Pollution Control and  Remediation,Hubei Polytechnic University,Huangshi 435003,China;3School of Environmental  Science and Engineering,Hubei Polytechnic University,Huangshi 435003,China
  • Online:2017-08-02 Published:2017-08-02

摘要: 紫杉醇是红豆杉属植物产生的一种次生代谢产物,由于紫杉醇对多种疾病具有较好的疗效,成为国内外研究的热点。为了探讨紫杉醇对肝癌细胞HEPG2的毒力,本实验采用溶剂浸提法从红豆杉叶片中提取紫杉醇,提取物中紫杉醇浓度可达1.436 μg/mg。经红外光谱证实,红豆杉提取物中的主要成分为紫杉醇。紫杉醇含量为2 μg/mL时,肝癌细胞HEPG2的相对死亡率最高,达到37.80%。经红豆杉叶片提取物处理的肝癌细胞HEPG2,培养至24 h,细胞开始变圆,膨大,分布松散,细胞褶皱,漂浮;培养至48 h,可明显观察到细胞坏死和碎片状,表现出较强的抑制作用。实验结果显示,红豆杉叶片提取物在治疗肝癌细胞HEPG2的药物开发方面具有研究的潜力。

关键词: 红豆杉, 紫杉醇, 肝癌细胞HEPG2, 毒力测定

Abstract: Paclitaxel is a secondary metabolite produced by plants of the genus taxuschinensis,has good curative effect for a variety of disease,which makes it become a hot spot in domestic and abroad.It is extracted from TaxusLinn leaves by the solventextraction method to explore the poisonous force of paclitaxel on liver cancer cell HEPG2,the content of paclitaxel in extractive is 1.436 μg/mg.The main composition of taxuschinensis extract is paclitaxel,which has been confirmed by HTIR.When the concentration of paclitaxel is 2 μg/mL the relative death rates of HEPG2 cells are the highest,to be 37.80%.The HEPG2 cells are handled by the taxuschinensis extract,the cells begin to turn round,enlargement,loosely arranged,cell fold,floating after 24 hours,the cells are necrosis and fragmented in 48 hours,which shows the extractive has the strong inhibition to the HEPG2 cells.The experimental results reveal that the taxuschinensis extract has the potential in the study of drug development for the treatment of liver cancer cell HEPG2.

Key words: Taxus Linn, paclitaxel, liver cancer cell HEPG2, toxicity determination